Automated three-dimensional total-body photography improves the efficiency of positive malignant biopsies and reduces ...

Image credit: Shutterstock / Sundry Photography. Genentech has secured a second marketed ... GlobalData is the parent company of Pharmaceutical Technology. Boehringer Ingelheim markets Activase and ...

(Image Credits: Pixabay) Boehringer Ingelheim’s blockbuster diabetes drug, Empagliflozin, is now off-patent in India, paving the way for domestic drugmakers to launch generic versions.

A clade is a group of viral strains that share a common ancestor. While traditional bird flu vaccines often only cover one clade at a time, Boehringer Ingelheim leveraged a technology called COBRA ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

On Tuesday, Boehringer Ingelheim’s Empagliflozin became off-patent in India. Major domestic drugmakers are expected to launch their generic versions soon. According to the company’s statement ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Sometimes, it’s also a bit silly. The Nikon Comedy Wildlife Photography Awards has released 17 previously unseen submissions to its 2024 competition that celebrate the lighter side of the animal ...

On Tuesday, the World Photography Organisation unveiled the shortlisted entries and finalists in its annual competition’s 10 professional categories. In each of the categories — which span ...

Since then she has promoted the adoption of such imaginative dog breeds as the “Teacup werewolf” and the “Speckled freckled ...

The winning entries for the 2025 World Nature Photography Awards aren't just technically solid images of Earth's diverse fauna and landscapes. This time around, you'll find astonishingly beautiful ...